Table 5. Toxicities comparison between Arm A (standard chemoradiotherapy) and Arm B (standard chemoradiotherapy plus consolidation chemotherapy).

Toxicity/number of patients (%)	Arm Aa (N = 65)										Arm Bb (n = 71)
	Grade 0		Grade 1		Grade 2		Grade 3		Grade 4		Grade 0		Grade 1		Grade 2		Grade 3		Grade 4
	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
Gastrointestinal reaction	8	12.3	10	15.4	41	63.1	2	3.1	4	6.1	0	0	20	28.2	43	60.6	2	2.8	6	8.4
Radiation enteritis	39	60	16	24.6	10	15.4	0	0	0	0	20	28.2	43	60.6	8	11.2	0	0	0	0
Radiation cystitis	45	69.2	4	6.2	16	24.6	0	0	0	0	39	54.9	20	28.2	12	16.9	0	0	0	0
Radioepidermitis	30	46.2	27	41.5	8	12.3	0	0	0	0	24	33.8	41	57.7	6	8.5	0	0	0	0
Myelosuppression	12	18.5	19	29.2	26	40	8	12.3	0	0	1	1.4	18	25.4	34	47.9	18	25.3	0	0

^aArm A consisted of paclitaxel plus cisplatin chemotherapy combined with radiotherapy.

^bArm B consisted of paclitaxel plus cisplatin chemoradiotherapy followed by paclitaxel plus cisplatin consolidation chemotherapy.